Drug Shortage Report for INDIUM DTPA IN 111
Report ID | 104510 |
Drug Identification Number | 02329093 |
Brand name | INDIUM DTPA IN 111 |
Common or Proper name | Pentetate Indium Disodium In 111 |
Company Name | GE HEALTHCARE CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | PENTETATE INDIUM DISODIUM IN 111 |
Strength(s) | 37MBq |
Dosage form(s) | SOLUTION |
Route of administration | INTRATHECAL |
Packaging size | 1.5 mL |
ATC code | V09AX |
ATC description | |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | 2020-06-17 |
Actual start date | |
Estimated end date | 2020-07-16 |
Actual end date | 2020-05-19 |
Shortage status | Avoided shortage |
Updated date | 2020-05-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
Company contact information | 800-387-7146 canadainfo@gehealthcare.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2020-05-19 | French | Compare |
v8 | 2020-05-19 | English | Compare |
v7 | 2020-01-29 | French | Compare |
v6 | 2020-01-29 | English | Compare |
v5 | 2020-01-29 | French | Compare |
v4 | 2020-01-29 | English | Compare |
v3 | 2020-01-29 | English | Compare |
v2 | 2020-01-29 | English | Compare |
v1 | 2020-01-28 | English | Compare |
Showing 1 to 9 of 9